Kevan Herold
Professor of Immunobiology and Internal Medicine · Yale University
Kevan Herold is Professor of Immunobiology and Internal Medicine at Yale University and led the trials of teplizumab, which delays stage 3 type 1 diabetes.
About
Kevan Herold is Professor of Immunobiology and Internal Medicine at Yale University and led the trials of teplizumab, which delays stage 3 type 1 diabetes. His grand rounds lecture traces autoimmune diabetes after anti-PD-1 therapy through C-peptide loss, HLA-DR4 associations and NLRC5 mutations.
Taught with
Same subject, Medicine & Health
Connections
6Their places, courses, books and lectures.
